Jim Cramer's Mad Money Review

This site is dedicated towards tracking Jim Cramer's stock picks on his TV show Mad Money. Read about and discuss Jim Cramer's ability to move markets. Be ahead of the stock market. Get the news before its news.

Tuesday, February 12, 2008

Jim Cramer's Mad Money Stock Recap Feb. 11th

Altria (MO), Bank of America (BAC), Chevron (CVX), Honeywell (HON), Conco-Phillips (COP), Freeport-McMoran (FCX), Schlumberger (SLB), American International Group (AIG), Pfizer (PFE), Cisco (CSCO)
Cramer was disappointed with Dow Jones' facelift which involved getting rid of Altria, and Honeywell, and adding Bank of America and Chevron. Three economic themes Cramer thinks should have been expressed in the Index changes are the growing importance of natural resources, the dwindling power of the financial sector and international growth. None of these themes were reflected in today's choices, Cramer commented. He said a financial should have been removed rather than added to the Dow, COP would have been a better choice than CVX, and would have considered including FCX or SLB in addition to keeping HON. He would have dropped AIG which is a travesty masquerading as an insurance company whose CEO, Martin Sullivan, was recently added to Cramer's Wall of Shame. He would also give Pfizer the pink slip, and would consider adding CSCO, since it is diversified.
Raytheon (RTN)
In spite of Goldman's Sachs note of Early indications of slowing growth in defense spending..., the military budget keeps growing; President Bush is asking for a $515 million for 2009 which is a 7.5% increase. Cramer likes RTN in this space because it has strong international sales, and is up 25% since Goldman's downgrade last March, but he would wait for a pullback before buying.
McDonald's (MCD), Darden (DRI)
One month of data does not justify a bearish position on a restaurant stock, said Cramer, noting McDonald's $6 rise since Bear Stearns hastily downgraded the stock for weak December same store sales (January same store sales increases 5.7%) An even faster kneejerk (or, rather, prejerk) occurred when Darden was downgraded only a few minutes before its better-than-expected guidance was released. The moral of the story, according to Cramer, is that when analysts unfairly downgrade stock on scant data, it is time to buy. Cramer would buy MCD now even though it has risen a bit.
Published By SeekingAlpha

Labels: , , , , , , , , , , , , , ,

Friday, November 23, 2007

CNBC's Fast Money Recap Nov. 22nd

The Dow closed down 211 points and the Nasdaq finishing down 34. The S&P 500 has now given up all of its gains on the year. Najarian continues to like the four horseman names like Apple (AAPL), Google (GOOG) and Research In Motion (RIMM) which showed strength on Wednesday. Adami recommended getting long General Motors (GM) right here with a specific stop price in mind. Finerman found it strange that Fannie Mae (FNM) went up Wednesday. Crude oil came close to $100 on Wednesday, but fell just short and finished the day at $97.19. Gartman feels the stock market is behaving horribly and he is short names like Harley-Davidson (HOG), Tiffany (TIF) and Coach (COH) and long Microsoft (MSFT)and Apple (AAPL). Gartman's favorite position right now is short Cummins (CMI).
CNBC Pharmaceuticals Reporter Mike Huckman joined the show to discuss his take on big pharma stocks. Huckman explained that Pfizer (PFE) is having issues with safety concerns on a stop smoking drug, falling Lipitor sales and generic competition. Huckman also mentioned that Merck (MRK), Eli Lilly (LLY) and Bristol Myers (BMY) were all down on Wednesday. Finerman likes Johnson & Johnson (JNJ).
Investors tend to sell their biggest losers towards the end of the year to reduce the tax hit they take from their winners. Some of the names at 52-week lows are Citigroup (C), Pfizer (PFE), Merck (MRK), J.C. Penny (JCP), Capital One Financial (COF), Advanced Micro Devices (AMD) and AIG (AIG).
Word on the Street
Macke recommended buying The Gap (GPS) on dips. Finerman likes Limited (LTD) on valuation. Adami suggested buying Citi Trends (CTRN) ahead of earnings for Monday. Najarian likes Target (TGT) for its valuation in retail.
Deere & Company (DE) traded up 5% after profits rose 52%.
Najarian suggests looking at Agco (AG)
Najarian noted strong call options trading activity on Tibco Software (TIBX).
Pops & Drops
Pops - Google (GOOG) traded up 2%
U.S. Steel (X) traded up 5% also bucking the down trend in the market.
Drops - Tesoro (TSO) fell 3%
American International Group (AIG) fell 6%.
Circuit City (CC) fell 6% after a JPMorgan analyst downgraded the stock.
Jamba Juice (JMBA) plunged 30%
Final Trade
Macke says don't buy stocks if you don't have to and Adami and Finerman just gave thanks in the holiday spirit.
Najarian likes Apple (AAPL) and he thinks the stock will explode into January.

Labels: , , , , , , , , , , , , , , , , , , ,

Tuesday, October 09, 2007

Hot Dividend Stocks

Company
Market Cap (billions)
Yield

General Electric (NYSE: GE)
$424
2.7%
AT&T (NYSE: T)
$258
3.4%
Citigroup (NYSE: C)
$232
4.6%
Bank of America (NYSE: BAC)
$223
5.0%
Vodafone (NYSE: VOD)
$193
3.9%
Pfizer (NYSE: PFE)
$169
4.8%
Home Depot (NYSE: HD)
$55
2.8%

Source: Fool.com

Labels: , , , , , , , ,

Hot Dividend Stocks

Company
Market Cap (billions)
Yield
General Electric (NYSE: GE)
$424
2.7%
AT&T (NYSE: T)
$258
3.4%
Citigroup (NYSE: C)
$232
4.6%
Bank of America (NYSE: BAC)
$223
5.0%
Vodafone (NYSE: VOD)
$193
3.9%
Pfizer (NYSE: PFE)
$169
4.8%
Home Depot (NYSE: HD)
$55
2.8%

Source: Fool.com

Labels: , , , , , , , ,

Friday, August 17, 2007

Jim Cramer's Wall Street Confidential Aug. 16th

PepsiCo (NYSE: PEP - News), Pfizer (NYSE: PFE - News), Schering-Plough (NYSE: SGP - News), Kellogg (NYSE: K - News), General Mills (NYSE: GIS - News), Altria (NYSE: MO - News), CVS Caremark (NYSE: CVS - News), MedcoHealth (NYSE: MHS - News), Cardinal Health (NYSE: CAH - News)
Cramer says almost everyone, including him, is "getting killed" in this market, and he wants viewers to understand "why it's so cataclysmic out there, so at least they have the grounding to say, 'OK, I'm willing to ride this out." While some suggest getting out of stocks, Cramer recognizes many people invest for the long term. However, he added; "What I'm trying to do is focus on what can work and what will really be hurt, not what's working, because nothing's working." Cramer said he got through the credit crunch in 1990s by focusing on the bull market and on 20 stocks that weren't losing. Examples may be PEP, PFE, SGP, K, GIS, MO, CVS, MHS, CAH. While he may have 10 to 1 bears out of every stock pile, Cramer urges viewers to "recognize that as the Federal Reserve continues to do a de facto tightening, you're going to continue to have spillover."
Published by SeekingAlpha

Labels: , , , , , , , , , ,

Thursday, August 16, 2007

Jim Cramer's Stop Trading Aug. 15th

Pepsi (NYSE: PEP - News), Procter & Gamble (NYSE: PG - News), Schering-Plough (NYSE: SGP - News) and Pfizer (NYSE: PFE - News): Cramer says the household goods sector is healthy given Pepsi's rise after Goldman Sach's downgrade. He also likes PG and SGP. He commented this sector did well during the 1990s' credit crisis which he compares to current subprime woes. Cramer would even think about Pfizer on the principle that "if anything good happens at Pfizer, you've got a good upside."

Labels: , , , , ,

Friday, August 03, 2007

Jim Cramer's Mad Money Stock Recap Aug. 2nd

Dow but not Out: JPMorgan Chase (NYSE: JPM - News), General Motors (NYSE: GM - News), Citigroup (NYSE: C - News), AIG (NYSE: AIG - News), Honeywell (NYSE: HON - News), DuPont (NYSE: DD - News) and Hewlett-Packard (NYSE: HPQ - News), AT&T (NYSE: T - News), Verizon (NYSE: VZ - News), Pfizer (NYSE: PFE - News) and Merck (NYSE: MRK - News)
After its mid-week drop, the Dow's rally on Thursday inspired Cramer to express confidence in the market and to repeat his prediction that the Dow will reach 14, 548 by the end of the year. He notes only four Dow stocks, JPM, GM, C and AIG are levered to current problems and only JPM and C are directly connected to mortgages. However, he commented HON, DD and HPQ have "beautiful" balance sheets and T, VZ, PFE and MRK will be able to survive the current market. Because of the strength of these stocks, the Dow wasn't crushed yesterday like it was "supposed to be," Cramer said.
The Windy City Merger: CME Group (NYSE: CME - News)
A good way to profit from the vicissitudes of the current market is to invest in CME, which Cramer recommends following its acquisition of the Chicago Board of Trade. Cramer likes the merger so much he thinks the Justice Department should never have allowed it to happen, since CME now has its "hands into everything" and can charge whatever it wants. While CME is trading at 30 x earnings, it is growing at a 20% clip this year, and its growth rate should reach 30% in 2008.
Sell Block: Buffalo Wild Wings (NasdaqGS: BWLD - News), General Cable (NYSE: BGC - News), Mastercard (NYSE: MA - News)
Since BWLD, BGC and MA got crushed after reporting better-than-expected quarters, Cramer explained "why bad things happen to good stocks." First, since all three had been rising rapidly, the bar was raised and "better-than-expected" just wasn't good enough for The Street. Second, there was a "hair" on each quarter, which is Wall Street jargon for a small flaw, or "hair" on a better-than-expected number. It was alleged that MA experienced domestic slowing, BWLD had slightly lower same-store sales and BGC had a downbeat outlook. However, Cramer said the main trick is knowing when to get rid of stock; "You can't count on me to tell you when to sell," he warned listeners, adding he can't always call a top. He said it is safe to sell the stocks now, since they are still high.
CEO Interview: Gregory Milzcik Barnes Group (NYSE: B - News)
Gregory Milzcik says his company is in the "sweet spot" of the current cycle; "We focus on difficult-to-manufacture parts but are also positioned great on high-volume, high-growth platforms, like that of the 787." He adds analysts are not really disappointed with the company, but want to see sales and margin growth, which Barnes Group can deliver. The company has expanded into Europe's "booming" market. Cramer commented; "Let the downgrades come, and then I would buy some. This stock's just way too cheap when it gets down to $20."
Published by SeekingAlpha

Labels: , , , , , , , , , , , , , , , , ,

Tuesday, May 29, 2007

Jim Cramer's Mad Money Stock Recap May 25

More Dow Picks: Pfizer (NYSE: PFE - News), Procter & Gamble (NYSE: PG - News), United Technologies (NYSE: UTX - News), Verizon (NYSE: VZ - News), Wal-Mart (NYSE: WMT - News), Walt Disney (NYSE: DIS - News)
Cramer says PFE is "stuck" and owning the stock is a bit like owning a bond with a tad more upside. He admits he was too bullish on PG when he predicted it could go to $67 on the weak dollar and organic growth. However, Cramer says he wasn't bullish enough on UTX which is doing well internationally and is in "hyper-drive." He predicts UTX is headed to $73. Cramer also admits he underestimated VZ's fiberoptics and its wireless, and he would buy it for its yield and growth in spite of its 14% rise. WMT should go to $52 but not higher, predicts Cramer, as long as CEO Lee Scott is in charge. While he likes DIS, he thinks its parks will be casualty to gas prices and the success of its Pirates of the Caribbean film is priced into the stock.
Call Me Darling (AMEX: DAR - News)
Cramer says Darling is "as speculative as it gets" with one business that transforms animal fats into oil and a restaurant business. DAR is "en fuego," but Cramer would wait for a big selloff before buying. After that, DAR needs more analysts covering it before it tops off, and Cramer predicts the stock will go "through the roof" when it moves into the renewable energy sector. Like Tyson, DAR could go into biodiesel, but it will get pummeled first, and when it does, Cramer would buy.
Game Plan for the Coming Week: Polo Ralph Lauren (NYSE: RL - News), Costco (NasdaqGS: COST - News), Sears (NasdaqGS: SHLD - News)
Cramer would stay away with tech, and would move into retail. He recalled RL got "creamed" after its last quarter, which was excellent, but which led to a selloff because of a negative perception about the company's guidance. Therefore, Cramer would buy half a position before RL reports and half after. While he praises COST as a "delivery machine" he believes the company will continue to be misunderstood, and would buy after its earnings report. Cramer suggests pickkng up SHLD if it gets pummeled, and if not, to wait for the next drop in the stock.
CEO Interview: Catherine Burzik, Kinetic Concepts (NYSE: KCI - News)
Catherine Burzik wanted to reassure viewers that KCI will not be hurt by competition from Smith & Nephew after its BlueSky Medical acquisition. "I'm not sure the analysts and the Street understand the market we are in here," she said. "This is a really large market ... and it is significantly unpenetrated. There's a really large opportunity." Burzik added that since Americans are getting "fatter by the day," there will be a great demand for KCI's therapeutic services. Cramer gives the company a triple buy.
Published by SeekingAlpha

Labels: , , , , , , , , , , , ,

Tuesday, May 22, 2007

Jim Cramer's Stop Trading May 21st

Transocean (NYSE: RIG - News), Halliburton (NYSE: HAL - News), and Schlumberger (NYSE: SLB - News): John Roque is a "man to be reckoned with," according to Cramer, who said he would take a look at Roque's three favorite natural gas plays. Cramer comments RIG reminds him of SLB in the early 80s when it experienced "one of the greatest runs I've ever seen in my career." He still likes HAL in spite of its "frustrating" slow performance.
Intel (NasdaqGS: INTC), Pfizer (NYSE: PFE - News), Glaxo (NYSE: GSK - News), Deere (NYSE: DE - News), Caterpillar (NYSE: CAT - News), Parker-Hanifin (NYSE: PH - News), Foster-Wheeler (NasdaqGS: FWLT): Cramer says tech and drug sectors are seriously "challenged" while "the sky's the limit" for DE, CAT, PH, FWLT, and the agriculture and machinery space in general. On the other hand, Cramer said "Forget the Intels," and said of PFE; "They fire everybody and it's up a penny!" He would also avoid GSK.

Labels: , , , , , , , ,

Tuesday, April 10, 2007

Hot Stocks to Watch for Today

Bullish
5+ Consecutive Down Days: These are stocks that have closed down for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that close down for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
LSI Logic (NYSE:LSI - News). LSI's PowerRating is 7.
5+ Consecutive Lower Lows: These are stocks that have made a lower low for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that make lower lows for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Vanda Pharmaceuticals (NasdaqGM:VNDA - News). VNDA's PowerRating is 8.
2-Period RSI Below 2: These are stocks that have a 2-period RSI reading below 2 and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving with a 2-period RSI reading below 2 have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
United Industrial (NYSE:UIC - News) & Life Time Fitness (NYSE:LTM - News). UIC's PowerRating is 7, and LTM's PowerRating is 6.
Stocks Down 10% or More: These are stocks that have lost 10% or more over the past five days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that have lost 10% or more over the past five days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Radvision (NasdaqGS:RVSN - News). RVSN's PowerRating is 7.
Bearish
5+ Consecutive Up Days: These are stocks that have closed up for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that close up for five or more days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge. Historically, these stocks have provided traders with a significant edge.
Pfizer (NYSE:PFE - News). PFE's PowerRating is 4.
2-Period RSI Above 98: These are stocks that have a 2-period RSI reading above 98 and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving with a 2-period RSI reading above 98 have shown negative returns, on average, 1-day and 1-week later. Historically, these stocks have provided traders with a significant edge.
Molina Healthcare (NYSE:MOH - News). MOH's PowerRating is 3.
PowerRatings are courtesy of PowerRatings.net

Labels: , , , , , , ,

Sunday, April 01, 2007

Wyeth (WYE) Sees Huge Potential by Barron's

Wyeth (NYSE:WYE - news) shares may rise 20 percent or more because its business is improving, its experimental drugs to treat patients with Alzheimer's disease are promising, and it could be an attractive takeover target, Barron's newspaper said in its April 2 edition.
The company's shares could rise into the 60s from Friday's close of $50.03, where the ratio of price to expected 2007 profit is 15 percent below typical peers among big drug companies, the newspaper said.
Wyeth shares trade at 14.5 times the average analyst forecast for $3.45 profit per share in 2007, according to Reuters Estimates. Fourth-quarter profit totaled $855 million, or 63 cents per share, and excluding items totaled 66 cents per share.
Barron's said Madison, New Jersey-based Wyeth should increase profit at 15 percent annually, regardless of whether any of its dozen Alzheimer's drugs under development pay off.
But it said if only a few of the drugs succeed, the company could generate hefty revenue should many of the 5 million Alzheimer's patients in the United States spend a few thousand dollars a year on treatments for the disease.
The newspaper said Enbrel, a product designed to treat arthritis, and Prevnar, a strep vaccine, should help lift cash flow and profit.
Another big product is the antidepressant Effexor, which generated about 18 percent of the fourth quarter's $5.22 billion of revenue.
The newspaper said Wyeth may also be near the end of incurring costs for its discontinued fen-phen diet drug, following a nationwide settlement and $21 billion of charges.
In addition, the newspaper said Wyeth is one of only a handful of drug companies that might be attractive merger partners for big rivals such as Pfizer Inc. (NYSE:PFE - news) and Switzerland's Novartis AG (NOVN.VX).
Wyeth's stock peaked at $70ред25 in April 1999. Its shares' 52-week high is $54.10, set on October 19, 2006.
Published by SeekingAlpha

Labels: , , ,

Monday, March 12, 2007

Jim Cramer's Mad Money Lightning Round Mar. 9

Bullish calls:
RPM International (NYSE: RPM - News): 'Rustoleum! The stock got hit for $2 bucks. Down to 3% yield again. C'mon! Back up the truck for RPM, one of the great long-term performers and, by the way, a very conservative management.'Six Flags (NYSE: SIX - News): 'You should buy SIX in the spring, ahead of the summer season... We had that guy Mark Shapiro on... That guy just rocks.'General Maritime (NYSE: GMR - News): ' Remember, I have not been a fan of the tanker stocks, but the one guy I trust is Georgiopoulos. He's the CEO. He's actually the founder. It's his money man. We've got to go with him.'Halliburton (NYSE: HAL - News): 'You keep your HAL! The prince ... is now the king! ... has a 10% buyback ... HAL is awakening from its slumber. It is now marching upward. It has been my value stock of the year.'Staples (NasdaqGS: SPLS): 'Sport, I recommended this thing right here (at its current price) and it has not moved at all. And yet, it keeps delivering and delivering and delivering. I am not abandoning it. It's one of the best-run retailers out there.'Hewlett-Packard (NYSE: HPQ - News): 'I like HPQ. It's been stuck here, under $40. I want you to make the switch out of the DELL and into the HPQ.'Under Armour (NYSE: UA - News): 'That stock holds in like you won't believe! ... I think the breakdown in Reebok, which is now owned by Adidas, where it's now going to lose a lot of shelf space, is going to be UA's gain. I like UA so much, that I have to contain myself!'Charter Communications (NasdaqGM: CHTR): ' ... this is the level. Anybody who bought CHTR at $3.10, you must buy it here. This company is going to be able to refinance and refinance and refinance, because interest rates are so low. I am sticking by CHTR. 'Graco (NYSE: GGG - News): 'I didn't believe that the stock should be this low. He does have a lot of North America that's weak... I think that guy is great. I would take advantage of the fact that GGG is down. Take advantage of his honesty. I would pull the trigger.'
Neutral calls:
Cadbury Schweppes (NYSE: CSG - News): 'It yields 3.68% and it's all the way down to $41?... I've got to look at that .... Let's do a segment on CSG - I don't know whether it's going to be positive or negative - next week.'
Bearish calls:
Bausch & Lomb (NYSE: BOL - News): ' Here's the deal: I think that BOL - as long as it's run by Ron Zarella - is a nightmare. And he is in my hall of shame. Sell, sell, sell! He's ridiculous. He should step down. And, you know what Ron? It's not personal. It's just business.'American Home Mortgage (NYSE: AHM - News): 'That dividend is 18%, and I think some large dividends, unlike hips, do lie. I want to be careful of that ... that dividend is a distinct red flag. I'm nervous.'Dell (NasdaqGS: DELL): 'No. Sell, sell, sell! No, Michael Dell cannot work miracles. I like HPQ*. It's been stuck here, under $40. I want you to make the switch out of the DELL and into the HPQ.'Iconix Brand (NasdaqGM: ICON): 'This stock has so much momentum that it actually - and I don't mean this to be negative - this one scare's me, it's got so much momentum... I keep reading about it virtually everywhere ... I don't want to buy it, even though I know it's doing the right thing. Don't buy, don't buy.'Gmarket (NasdaqGM: GMKT): 'You know, GMKT's bad ... This has been a tough market. GMKT I was too bullish on it ... I hope it really goes up so we can really dump on it and get everybody out of it.'Melco PBL Entertainment (NasdaqGM: MPEL):Micron Technology (NYSE: MU - News): 'Not in our lifetime. Sell, sell, sell! Stay away my friend!'Pfizer (NYSE: PFE - News):Crown Media Holdings (NasdaqGM: CRWN): 'Your stock stinks! Sell, sell, sell!'

Published By SeekingAlpha

Labels: , , , , , , , , , , , , , , , , , ,

Tuesday, January 23, 2007

Jim Cramer's Mad Money Lightning Round Jan. 22

Bullish calls:
Rite Aid (NYSE: RAD - News): 'One of the known communists on Wall Street downgraded RAD last week... I reiterate - at $5.80, RAD remains one of my favorite speculations. Take that bears!'China Mobile (NYSE: CHL - News): 'If you want to go to China, and you want to do phone, you've got to do CHL. I would actually recommend you swap out of CHU and go into CHL. Even as CHL is at its 52-week high, I think that's a better buy.'Genentech (NYSE: DNA - News): 'If we want to be in pharma, we're going to be in DNA, or we're going to be in AMGN, and CELG!... 'Amgen (NASDAQ: AMGN - News)Celgene (NASDAQ: CELG - News)Flir Systems (NASDAQ: FLIR - News)Nice Systems (NASDAQ: NICE - News): ' If you want to be in defense, remember, we like FLIR or NICE, because we like homeland security!'Google (NASDAQ: GOOG - News): 'I think that's one of the few techs that I want to own. My friend, Anthony Notto, at Goldman Sachs, recently raised estimates ... I think the stock will get to $600.'Melco PBL Entertainment (NASDAQ: MPEL - News): 'People are starting to doubt me on that call... We're fine. (buzzer rings)... MPEL is not as good as LVS, and not as good as WYNN, but it should be bought here.'SkyWest (NASDAQ: SKYW - News): 'You know that I'm a liker of the airlines, but let's be careful. After the close of the market, AMR announced an offering of 13 million shares. That's going to cause some pressure in the group. SKYW should trade down a dollar on that, and then you could pull the trigger and buy more, but don't overstay your welcome.'Under Armour (NYSE: UA - News): 'Some publication... had this really negative article ... If you don't know Kevin Plank, then you don't know one of the best CEOs in America. I think UA is in a major bull-market mode. I think the shorts planted that story ... I like UA and I want you to stay with it.'
Bearish calls:
China Unicom (NYSE: CHU - News): 'No. No. I'm not a fan of CHU ... I would actually recommend you swap out of CHU and go into CHL.'Flextronics International (NASDAQ: FLEX - News): 'Maybe you're shorting it, because you're not going to make any money being long that. You need to be out of the contract manufacturing ... this is a bearish group!'Nektar Therapeutics (NASDAQ: NKTR - News): ' ... What is that, the 470th restructuring they announced today? Most of their restructuring just involves firing people... Heaven forbid they actually try to improve the company... No, we don't want to be anywhere near NKTR.'Pfizer (NYSE: PFE - News): ' ... another bear.'Force Protection (NASDAQ: FRPT - News): ' ... not for me. 'Imergent (AMEX: IIG - News): ' Electronic services to small businesses... to me, it's the definition of tech (bear sound)... No! This is a stock that is too darn hard. Sell, sell, sell!'
Published by SeekingAlpha

Labels: , , , , , , , , , , , , , , , , , ,

Monday, January 22, 2007

Stock Watch for Monday

A.O. Smith (NYSE:AOS - News) is looking to announce $0.50 EPS on Monday morning before the opening bell. AOS's PowerRating is 5.
Compass Banc (NASDAQ:CBSS - News) is reporting quarterly earnings on Monday before the open, with analysts expecting $0.90 EPS. CBSS's PowerRating is 6.
Eaton (NYSE:ETN - News) is expected to report $1.59 EPS on Monday morning before the bell. ETN's PowerRating is 5.
Lee Enterprises (NYSE:LEE - News) announces quarterly earnings on Monday morning; watch for $0.58 EPS. LEE's PowerRating is 5.
Analysts are expecting Pfizer (NYSE:PFE - News) to report $0.43 EPS Monday morning. PFE's PowerRating is 5
CSX Corporation (NYSE:CSX - News) and Texas Instruments (NYSE:TXN - News) both report Monday after the market closes, so watch for heightened price action and volatility ahead of the bell. CSX's PowerRating is 5, and TXN's PowerRating is 4.
PowerRatings are courtesy of PowerRatings.net

Labels: , , , , , ,

Tuesday, December 05, 2006

Onyx Pharmaceuticals Inc. (ONXX) Stock Drops on Drug Failure

Shares of Onyx Pharmaceuticals Inc. (ONXX.O: Quote, Profile , Research) fell nearly 30 percent on Monday after data showed that its kidney cancer drug Nexavar did not work in patients with advanced skin cancer. Onxy and its partner Bayer AG (BAYG.DE: Quote, Profile , Research) of Germany said a late-stage trial of the drug in combination with chemotherapy did not meet its main goal of improving progression-free survival, or the period in which a patient experiences no meaningful tumor growth. Last month Bayer said it expected sales of Nexavar to top $133 million this year and eventually to generate sales of at least $1 billion. The drug competes with Pfizer Inc's (PFE.N: Quote, Profile , Research) Sutent. Shares of Onyx dropped to $12.25 from $17.50 on Nasdaq on Friday. Bayer's shares were up 1.1 percent at 39.26 euros.
Source: Reuters.com

Labels: , , , , ,

Tuesday, November 21, 2006

Jim Cramer's Stop Trading-Nov. 20

Research In Motion (NASDAQ: RIMM - News): Cramer says that RIMM is rallying like a "running back that has just broken through the Rutgers defense," and expects the surge to continue through the holidays. Allergan (NYSE: AGN - News), Merck (NYSE: MRK - News) and Pfizer (NYSE: PFE - News): Cramer called Allergan a "genius company" with its popular Botox and other products. He notes that it is up $7 at $119, and may be an attractive acquisition for Merck or Pfizer. Phelps Dodge (NYSE: PD - News), Equity Office (NYSE: EOP - News) and Freeport (NYSE: FCX - News): Recent mergers like those of PD-FCX and EOP demonstrate that "everything is cheap to someone in this market," remarks Cramer. Freeport picked up PD because it needed more copper, and since metals are "so hated by mutual funds" the acquisition was inexpensive. Cramer added that there is a lack of supply in good stocks and "All the managements I know think stocks are undervalued," he added. "So many companies want to buy other companies."

Labels: , , , , , , , ,